Veletri and Paleness - a phase IV clinical study of FDA data
Summary:
Paleness is reported as a side effect among people who take Veletri (epoprostenol sodium), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Opsumit, and have Primary pulmonary hypertension.
The phase IV clinical study analyzes which people have Paleness when taking Veletri. It is created by eHealthMe based on reports of 14,192 people who have side effects when taking Veletri from the FDA, and is updated regularly.
What is Veletri?
Veletri has active ingredients of epoprostenol sodium. eHealthMe is studying from 14,196 Veletri users. Check the latest studies of Veletri.
What is Paleness?
Paleness (unusual lightness of skin colour) is found to be associated with 1,552 drugs and 2,119 conditions by eHealthMe. Check the latest studies of Paleness.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14,192 people reported to have side effects when taking Veletri.
Among them, 148 people (1.04%) have Paleness.

Among these 148 people:
How long have people been on Veletri when they have Paleness? *
What is the gender of people who have Paleness when taking Veletri? *
What is the age of people who have Paleness when taking Veletri? *
What are other drugs people take besides Veletri? *
What are other side effects people have besides Paleness? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Veletri and have Paleness?
- Check whether Paleness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Veletri:
- Veletri (14,196 reports)
Paleness treatments and more:
- Paleness (34,670 reports)
How severe was Paleness and when was it recovered:
Expand to all the drugs that have ingredients of epoprostenol sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Veletri:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Paleness:
- Paleness (1,552 drugs)
Browse all the conditions that are associated with Paleness:
- Paleness (2,119 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on epoprostenol sodium (the active ingredients of Veletri) and Veletri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prevacid cause Physical Assault? - 13 seconds ago
- Drug interactions of Letermovir and Tamsulosin - 16 seconds ago
- Drug interactions of Orencia and Lys - 16 seconds ago
- Could Varenicline Tartrate cause Haematuria? - 22 seconds ago
- Could Xenazine cause Anaemia? - 29 seconds ago
- Could Capecitabine cause Musculoskeletal Disorder? - 30 seconds ago
- Isosorbide Mononitrate and Confusional State for Women aged 60+ - 38 seconds ago
- Could Fosamax cause Poor Peripheral Circulation? - 47 seconds ago
- Could Folic Acid cause Pseudomonas Aeruginosa Infection? - 55 seconds ago
- Could Atripla cause Dyspnea Exacerbated? - 55 seconds ago